Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics - Frost & Sullivan is proud to present the 2009 North American Healthcare Innovation Award in molecular diagnostics to Intelligent Medical Devices, Inc
Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics

 

PRZOOM - /newswire/ - Mountain View, CA, United States, 2009/12/17 - Frost & Sullivan is proud to present the 2009 North American Healthcare Innovation Award in molecular diagnostics to Intelligent Medical Devices, Inc.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Frost & Sullivan is proud to present the 2009 North American Healthcare Innovation Award in molecular diagnostics to Intelligent Medical Devices, Inc. (IntelligentMDx) for its commitment to providing innovative technologies for the advancement of healthcare and diagnostics. Since its incorporation in 2004, IntelligentMDx has introduced a proprietary novel and innovative bioinformatics approach to make tests that are clinically impactful, competitively differentiated, and platform agnostic.

There is an enormous market demand for robust diagnostic tests that allow for definitive diagnosis and effective treatment. Of equal importance is a test's ability to differentiate variations between infectious disease agents – while a strain of pathogen might exhibit only minor changes at the protein level, existing tests can prove inadequate to identify significant genetic deviation from the wild type. Thus, innovative tests that employ a sequence-based approach to diagnosis at the molecular level have superior clinical potential.

Specifically, today's molecular diagnostic platforms are providing unparalleled clinical value, especially for diagnosis of infectious diseases. Moreover, these molecular diagnostic technologies are smaller, less expensive, and more user-friendly than their predecessors, driving the adoption and utilization of new innovative tests.

"By the mid-2020's, physicians are expected to employ these technologies at the point-of-care and improve the economics of patient care substantially" says Frost & Sullivan Industry Manager Jonathan Witonsky. "Companies that are developing these tests that streamline the overall cost of patient care will have a significant competitive advantage with the advancement of healthcare."

IntelligentMDx collaborates with thought leading stakeholders to understand the current needs of molecular testing, and it employs unique and proprietary bioinformatics processes for the accelerated production of high-quality assays. Built into this process is the incorporation of a network of inputs from expert end users to pre-set the clinical indications and specifications for an assay. IntelligentMDx's innovative technology and process enables a better understanding for nucleic acid to nucleic acid interactions and thus can enhance the development of tests of any molecular application.

The company's in silico design and analysis process allows it to avoid a long trial and error approach, requires less wet lab experimentation to show that a solution is valid, and meets the highest performance standards. IntelligentMDx's approach to producing clinically relevant assays decreases the test development time so it can provide the best solutions to clinicians and patients sooner, while avoiding some of the risks of bringing products to market.

IntelligentMDx is developing products in a breadth of markets, including Seasonal/Pandemic Influenza, Bordetella, Immunocompromised patient care and Infection Control testing including antimicrobial resistance screening and detection. Using this approach, the company has developed relationships with many clinical reference labs. Such close collaborations with customers have enabled IntelligentMDx to understand the economics of labs and challenges that users face with existing methods.

Further, IntelligentMDx's tests are designed and developed under FDA quality system regulations and, therefore, are accompanied with reduced risks. The company has a very strong intellectual property portfolio and holds US and foreign patents and pending patent applications on, including, individual test sequences and methods of using the assays and sequences.

For its commitment to providing innovative technologies for the advancement of healthcare and diagnostics, Frost & Sullivan is pleased to present the 2009 Healthcare Innovation Award to IntelligentMDx for its demonstrated leadership in the molecular diagnostics markets.

Each year, Frost & Sullivan presents this award to the company that has exhibited a breakthrough approach / degree of differentiation innovation compared to other market participants in terms of unique or revolutionary technology. The award recognizes outstanding penetration rate of new markets and the significance of the innovation within the industry. It also recognizes the recipient for leading proactive initiatives to improve value to customers and advancement of the industry through its research.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About IntelligentMDx

IntelligentMDx (intelligentmdx.com) is a commercial stage molecular diagnostics company that makes tests that are clinically impactful, competitively differentiated, and platform agnostic. We have product offerings for Seasonal/Pandemic Influenza, Bordetella, Immunocompromised patient care and Infection Control testing including antimicrobial resistance screening and detection. IntelligentMDx commercializes molecular diagnostic test solutions under FDA QSR, ISO 13485:2003 and IVDD regulations and guidances for use in clinical reference laboratories. IntelligentMDx, Inc., a privately held company, is based in Cambridge, MA.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Jake Wengroff 
210.247.3806 jake.wengroff[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today